Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
concetta.potenza@uniroma1.it
Concetta Potenza
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
concetta.potenza@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Effectiveness of tralokinumab in different phenotypes of atopic dermatitis. A real-world study
DERMATOLOGY AND THERAPY
2025
Risankizumab versus Secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy
DERMATOLOGY PRACTICAL & CONCEPTUAL
2025
Gender differences in adult atopic dermatitis and clinical implication: results from a nationwide multicentre study
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2024
Efficacy and safety of tildrakizumab in elderly patients. Real-world multicenter study (ESTER - study)
JOURNAL OF DERMATOLOGICAL TREATMENT
2024
Extracellular vescicles in psoriasis. From pathogenesis to possible roles in therapy
FRONTIERS IN IMMUNOLOGY
2024
BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy
MELANOMA MANAGEMENT
2024
Efficacy and safety of intra-class switching from Ixekizumab to Secukinumab in patients with plaque psoriasis. A multicenter retrospective study
JOURNAL OF PERSONALIZED MEDICINE
2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
JOURNAL OF DERMATOLOGICAL TREATMENT
2024
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY
2024
Safe Integration of Encorafenib plus Binimetinib with Stereotactic Radiosurgery for Melanoma Brain Metastases: a Case Report
LA CLINICA TERAPEUTICA
2024
Rapid efficacy of riSankizumab in pretibial psoriasis invOLVEment. RESOLVE
DRUGS IN CONTEXT
2024
Hyaluronic acid fillers for cosmetic and functional correction in thyroid eye disease
JOURNAL OF COSMETIC DERMATOLOGY
2024
Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab
INDIAN JOURNAL OF DERMATOLOGY
2024
Rapid response on facial psoriasis to bimekizumab: case series
DRUGS IN CONTEXT
2024
Successful treatment with Bimekizumab of a psoriatic patient undergoing hemodialysis. A case report and review of the literature
JOURNAL OF CLINICAL MEDICINE
2024
18F-FDG PET-CT scans in oncology patients treated with hyaluronic acid filler: not always a pitfall
CASE REPORTS IN ONCOLOGICAL MEDICINE
2024
Extreme makeover filler edition. Non-surgical correction for facial deformities post-trauma
JOURNAL OF COSMETIC DERMATOLOGY
2024
Generalized eruptive keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty®) COVID-19 vaccination successfully treated with Cemiplimab
VIRUSES
2024
[$\less$sup$\greater$18$\less$/sup$\greater$F]{FDG} {PET}/{CT} in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological Findings
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS
2023
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study
THE JOURNAL OF DERMATOLOGICAL TREATMENT
2023
1
2
3
4
5
6
7
8
seguente ›
ultima »
ERC
LS4_1
LS4_6
Interessi di ricerca
Keywords
clinical trial
Progetti di Ricerca
Tumor microenvironment in melanoma treatment
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma